Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

Find Out More
Wellcome Trust Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Kent Featured PhD Programmes
Imperial College London Featured PhD Programmes
Max Planck Society Featured PhD Programmes
"cancer" AND "drugs"×
10 miles
    2. >
    3. >

cancer drugs PhD Projects, Programs & Scholarships

We have 67 cancer drugs PhD Projects, Programs & Scholarships

  • "cancer" AND "drugs" ×
  • clear all
Order by 
Showing 1 to 10 of 67
  Cardiotoxicity of cancer drugs targeting the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade
University of Reading School of Biological Sciences
  Prof A Clerk
Applications accepted all year round
"Heart failure is a leading cause of morbidity and mortality worldwide. The contractile cells of the heart, cardiomyocytes, possess many protective mechanisms, allowing them to withstand pathophysiological stresses.
Details
Type/Funding
  Exploration of novel approaches to anti-cancer treatment: manipulation of mutant p53
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Prof Y. Haupt, Dr S. Haupt
Applications accepted all year round
P53 is the most mutated gene in human cancer, affecting about half the cases of human cancer. We have recently identified novel regulators of mutant p53 using sophisticated loss of function whole genome high through put screen (image 1).
Details
Type/Funding
  Vitamin C microbubbles as therapeutic agents for colorectal cancer
University of Leeds School of Physics and Astronomy
  Prof SD Evans
Application Deadline: 7 January 2019
Recent published studies have shown that Vitamin C can target and kill colorectal cancer cells that contain gene mutations that are present in approximately 50% of colorectal cancer tumours.
Details
Type/Funding
  Magnetic hyperthemia for cancer treatment: synthesis, biofunctionalisation of nanoparticles for thermo-chemotherapy
University College London Department of Physics and Astronomy
  Prof N T K Thanh
Applications accepted all year round
Funded 3.5 years PhD. Open to UK nationals. Functional magnetic nanoparticles for cancer treatment. Supervisor. Prof Nguyen TK Thanh.
Details
Type/Funding
  MRC Precision Medicine DTP: Assessing the value of high-priced novel treatments in oncology in an era of precision medicine: methodological and policy tools
University of Glasgow College of Medicine, Veterinary and Life Sciences
  Research Group: Institute of Health and Wellbeing
  Prof A Briggs, Dr K Boyd
Application Deadline: 7 January 2019
Supervisors. Prof Andrew Briggs. Dr Kathleen Boyd. Dr Peter Bach. PhD project summary. Health systems around the world are struggling to accommodate the increasing cost of new cancer treatments.
Details
Type/Funding
  Chemical modulation of cellular redox balance for cancer treatment
University of Birmingham School of Pharmacy
  Dr I Romero-Canelon
Applications accepted all year round
Platinum complexes, cisplatin, oxaliplatin and carboplatin, are the most widely used anticancer drugs. However, these DNA-targeting treatments are a low selectivity approach with deleterious consequences and a high incidence of resistance.
Details
Type/Funding
  Understanding and targetting telomere maintenance in cancer
University of Oxford Radcliffe Department of Medicine
  Dr D Clynes, Dr A Blackford, Dr R Gibbons
Application Deadline: 11 January 2019
Cancer occurs through the uncontrolled growth and division of cells, which eventually leads to the development of a tumour. The number of times a cell can divide is limited by the length of specialised DNA sequences found at the end of chromosomes.
Details
Type/Funding
  DNA Damage and Disease: Studying the signalling mechanisms cells use to respond to DNA damage and why defects in these pathways cause human diseases such as cancer.
University of Oxford Radcliffe Department of Medicine
  Dr A Blackford, Dr D Clynes
Application Deadline: 11 January 2019
Studying the signalling mechanisms cells use to respond to DNA damage and why defects in these pathways cause human diseases such as cancer.
Details
Type/Funding
  Bioactivity of 3D sugar-based heparan sulfate clusters for treating cancer
Victoria University of Wellington Ferrier Research Institute
  Prof J Miller, Dr O Zubkova
Applications accepted all year round
A key factor in metastasis (the migration of cancer cells to remote parts of the body) is an enzyme called heparanase. It releases compounds from the extracellular matrix that encourage tumour growth.
Details
Type/Funding
  Synthesis and bioassays of 3D sugar-based clusters for treating cancer
Victoria University of Wellington Ferrier Research Institute
  Dr O Zubkova
Applications accepted all year round
A key factor in metastasis (the migration of cancer cells to remote parts of the body) is an enzyme called heparanase. It releases chemicals from the extracellular matrix that encourage tumour growth.
Details
Type/Funding
Show 10 15 30 per page
4k+

PhD Project & Programmes
Search for PhDs
PhDs by Subject
PhDs by Institution
PhDs by Country
PhDs by Email
Info for students
Postgraduate Open Days
PhD Study Guides
PhD Study Abroad
Funding Your PhD
Postgraduate Advice Forum
Postgraduate Email Updates
Info for advertisers
Advertise your PhD Project & Programmes
Provider Login
Display Advertising
Targeted Emails

FindAPhD. Copyright 2005-2018
All rights reserved.

Meet with top universities

Get funding advice

Win a £1,000 bursary